Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$79.29 USD

79.29
1,037,884

-1.20 (-1.49%)

Updated Nov 7, 2024 03:59 PM ET

After-Market: $79.32 +0.03 (0.04%) 5:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Instruments

Zacks News

DENTSPLY (XRAY) Earnings and Revenues Miss Estimates in Q1

DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 49 cents in the first quarter of 2017, missing the Zacks Consensus Estimate by 2 cents.

    Integer (ITGR) Q1 Earnings Miss, Revenues Beat Estimates

    Integer Holdings Corporation (ITGR) reported adjusted earnings of 41 cents per share in the first quarter of 2017, a penny down on a year-over-year basis.

      Phibro (PAHC) Posts In Line Earnings in Q3, Revises View

      Phibro Animal Health Corporation (PAHC) reported adjusted earnings per share (EPS) of 37 cents in the third quarter of fiscal 2017, down 7.5% year over year.

        Align Technology Invisalign Sales Strong, Currency Woes Stay

        On May 5, we issued an updated research report on Align Technology (ALGN), which manufactures a system of clear aligner therapy.

          Qiagen Banks on Molecular Diagnostic amid Currency Woes

          On May 4, we issued an updated research report on leading molecular diagnostic company, Qiagen N.V. (QGEN).

            CVS Down on Weak Earnings, Pharmacy Services Remains Strong

            On May 5, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).

              Abiomed (ABMD) Q4 Earnings Meet, Revenues Beat Estimates

              Abiomed posted a promising fourth quarter of fiscal 2017, with revenues beating the Zacks Consensus Estimate and earnings meeting the mark.

                VWR Corp (VWR) Beats on Q1 Earnings, Awaits Merger Closure

                VWR Corporation (VWR) reported first-quarter 2017 adjusted earnings per share (EPS) of 44 cents, reflecting a 10% rise from the year-ago quarter.

                  BioScrip (BIOS) Q1 Loss Narrower than Expected, Sales Miss

                  BioScrip, Inc. (BIOS) reported net loss from continuing operations of $19.4 million or a loss of 18 cents per share in the first quarter of 2017 compared with net loss of $9.5 million or a loss of 17 cents a year ago.

                    Allscripts (MDRX) Beats on Q1 Earnings, Revenues In Line

                    Allscripts Healthcare Solutions, Inc. (MDRX) reported first-quarter 2017 earnings of 10 cents per share, beating the Zacks Consensus Estimate by a penny.

                      Omnicell (OMCL) Q1 Loss Narrower than Expected, Revenues Lag

                      Omnicell, Inc. (OMCL) reported a loss per share of 29 cents in first-quarter 2017, reflecting a deterioration from the year-ago loss of a penny.

                        Wright Medical (WMGI) Posts Wider-than-Expected Loss in Q1

                        Wright Medical Group N.V. (WMGI) reported adjusted loss of 9 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 8 cents.

                          PerkinElmer (PKI) Tops Q1 Earnings Estimates, FY17 View Up

                          PerkinElmer Inc (PKI) reported first-quarter 2017 adjusted earnings of 55 cents per share, marginally beating the Zacks Consensus Estimate by a penny.

                            athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1

                            athenahealth Inc. (ATHN) reported adjusted earnings of 10 cents per share in the first quarter of fiscal 2017.

                              AmerisourceBergen (ABC) Beats on Q2 Earnings, Lags Revenues

                              AmerisourceBergen Corporation (ABC) posted adjusted earnings of $1.77 per share in the second quarter of fiscal 2017, beating the Zacks Consensus Estimate of $1.71 and increasing 5.4% on a year-over-year basis.

                                Cardiovascular Systems (CSII) Swings to Earnings in Q3

                                Cardiovascular Systems, Inc. (CSII) reported adjusted earnings per share of 3 cents in third-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's adjusted loss of 47 cents.

                                  Bruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates

                                  Bruker Corporation (BRKR) reported adjusted earnings per share (EPS) of 19 cents in the first quarter of 2017, lower than the year-ago figure by 9.5%.

                                    DaVita (DVA) Earnings Miss Estimates, Revenues Beat in Q1

                                    DaVita Inc. (DVA) reported first-quarter 2017 adjusted operating earnings of 79 cents per share that missed the Zacks Consensus Estimate of 82 cents.

                                      QIAGEN (QGEN) Beats Q1 Earnings Estimates, Retains View

                                      QIAGEN N.V. (QGEN) reported first-quarter 2017 adjusted earnings per share (considering restructuring expenses as one time item) of 22 cents, up 15.8% year over year.

                                        DexCom (DXCM) Q1 Loss Narrower than Expected, Revenues Miss

                                        DexCom Inc. (DXCM) reported a loss of 49 cents per share in the first quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 55 cents.

                                          Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View

                                          Myriad Genetics Inc. (MYGN) reported adjusted earnings per share (EPS) of 27 cents in the third quarter of fiscal 2017, down 34% year over year.

                                            Amedisys (AMED) Beats on Q1 Earnings, Revenues Meet Mark

                                            Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 47 cents per share in the first quarter of 2017, up 42.4% year over year.

                                              CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y

                                              CVS Health Corporation (CVS) reported first-quarter 2017 adjusted earnings per share (EPS) of $1.17, down 0.8% year over year.

                                                Ecolab (ECL) Q1 Earnings Miss Estimates, Revenues In Line

                                                Ecolab Inc. (ECL) reported first-quarter 2017 adjusted earnings (excluding special gains, charges and tax items) of 80 cents per share, which missed the Zacks Consensus Estimate of 81 cents.

                                                  Becton, Dickinson (BDX) Q2 Earnings Beat, Increase Y/Y

                                                  Becton, Dickinson and Company (BDX), popularly known as BD, reported second-quarter fiscal 2017 earnings of $2.30 per share, which beat the Zacks Consensus Estimate of $2.23 and increased 5.5% on a year-over-year basis.